Idiopathic CD4 Lymphopenia
2 clinical trials · Condition
◉ Watch Idiopathic CD4 Lymphopenia
| Record | Firm | Date |
|---|---|---|
| A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia (NCT05600920) | National Institute of Allergy and Infectious Diseases (NIAID) | 2024-11-06 |
| Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe) (NCT04097561) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-01-13 |
Track Idiopathic CD4 Lymphopenia automatically
Every clearance here is in the API, with alerts when new ones post.